Search – Page 25 – Indianapolis Business Journal

Home » Search

Articles

Citizens’ new name is a gas-in a way: Parent company of local utility adds ‘energy’ to its moniker to reflect diversity of operations

August 25, 2008

Citizens Gas & Coke Utility on Aug. 25 will announce a new name and logo that reflect the diversification of its energy businesses and the closure last year of its 98-year-old foundry coke plant. Citizens Energy Group will be the name of the parent, a utility founded 120 years ago. Two units-Citizens Gas and Citizens Thermal-will retain their names. But a third, Citizens By-Products, will be renamed Citizens Resources. “We’re entering a new era,” said Citizens President and CEO Carey…

Cautious contractors warm to Lilly-Covance deal: Drugmaker works to assuage fears of some local researchers worried they might lose lucrative work

August 25, 2008

When Eli Lilly and Co. announced Aug. 6 that it would more than double the amount of research and development work it outsources to Covance Inc., Dr. Alfonso Alanis got nervous. The CEO of contract researcher Anaclim LLC worried that more work for Covance would mean less work for local firms that provide drug development services to Lilly. Executives at other local firms, who asked not to be named because of confidentiality agreements with Lilly, also have fretted that their…

Cymbalta helps lower-back pain, Lilly says

August 25, 2008

Eli Lilly and Co. said its depression drug Cymbalta showed some effectiveness against chronic low back pain, according to data presented today in Spain. The study gives Lilly evidence to perhaps get Cymbalta approved to treat yet another medical condition. The drug already has approval to treat depression, generalized anxiety disorder, diabetic nerve pain and […]

Elanco home base moving to life sciences park

September 2, 2008

Elanco, the animal health division of Eli Lilly and Co., will move into a new 135,000-square-foot headquarters in Greenfield by the spring of 2010, the company announced today. Elanco’s new offices will go up on the northwest corner of State Road 9 and I-70, where Indianapolis developer Browning Investments Inc. is building a 52-acre life […]

Lilly continues to build case for prasugrel

September 3, 2008

Eli Lilly and Co. continued to press its case for regulatory approval of its blood thinner prasugrel today by releasing two more studies offering new analysis of prasugrel’s clinical trial data. The release comes weeks before the U.S. Food and Drug Administration is scheduled to rule on whether the drug should be allowed onto the […]

Zyprexa class action given green light

September 5, 2008

Enough evidence of fraud by Eli Lilly and Co. in its marketing of Zyprexa exists to go ahead with a jury trial, a judge in New York has ruled. Plaintiffs in the case claim Lilly urged physicians to prescribe the schizophrenia and bipolar disorder drug for uses not approved by the federal government. Insurance companies, […]

Commentary: Indiana law chases away talent

September 8, 2008

The Wellness Community of Central Indiana was established in 1995 as a not-for-profit organization to provide free support, education and hope to individuals and families affected by cancer. At The Wellness Community, cancer patients can share experiences and lend one another encouragement informally or through programs facilitated by professional counselors. The Wellness Community also provides a haven to grieve together in those instances when cancer is the ultimate victor. Today, the folks at The Wellness Community are grieving over a…

ON THE RECORD:

September 8, 2008

O N T H E R E C O R D First Merchants Corp. of Muncie announced Sept. 3 that it has agreed to buy Lincoln Bancorp of Plainfield for about $75 million. The acquisition expands First Merchants’ presence in the Indianapolis area from the northern suburbs into other fast-growing suburbs on the west and south sides. Announcement of the deal sparked a 37-percent runup in the value of Lincoln shares. Elanco, the animal-health division of Eli Lilly and Co.,…

Expectations high as Economic Club opens season: Group sees turnaround in sponsorships, attendance

September 15, 2008

Organizers of the Economic Club of Indiana believe they’ll hit a home run when their first speaker of the season, Eli Lilly and Co.’s new CEO, John Lechleiter, steps to the podium Sept. 24. “I believe John Lechleiter will blow the socks off the place,” predicted Steve Walker, who serves as club president and also is CEO of WalkerInformation. Just a few years ago, club organizers weren’t in a position to be so upbeat. Early this decade, the club witnessed…

Lilly Endowment crawls toward diversification goal: Bear market, low Lilly stock price slow selloff

September 15, 2008

Lilly Endowment Inc. is still on its journey to sell off $2 billion of its Eli Lilly and Co. shares. But after a slow start and a few stops for rest, it may take a little longer to get there than originally thought. The endowment, the single largest holder of Lilly stock, announced its plan to diversify its holdings back in July 2006. For nearly 70 years, the not-for-profit held its wealth almost exclusively in the pharmaceutical company’s stock. So…

Lilly CEO Lechleiter to become chairman

September 18, 2008

Eli Lilly and Co. announced today that CEO John Lechleiter will also gain the additional title of chairman on Jan. 1. Lechleiter will replace Sidney Taurel, who is retiring. Lechleiter took over for Taurel as CEO on April 1. Lilly directors today also named Taurel as chairman emeritus.

Orchestrating moves: Firm that specializes in relocating businesses conducting transition of its own

September 22, 2008

Moving coordinating company Relocation Strategies Inc. is used to dealing with companies in transition. Now the firm is undergoing one of its own-albeit of a different sort. Relocation Strategies founder David Bayse is relinquishing ownership to partner Melissa Lamb Brown in a purchase agreement set to be completed within the next four years. She already owns a majority of the business and will acquire the rest in stages. In the meantime, Bayse, 57, will continue to guide Brown, 39, who…

Lilly chief outlines plan to boost stock, image

September 24, 2008

Eli Lilly and Co. can restore its image and improve its stock price by doing a better job of touting benefits of the drugs it sells and turning research into new products faster. That’s the strategy CEO John Lechleiter planned to lay out today during a lunchtime speech to the Economic Club of Indiana. IBJ […]

Parks district to reuse RCA Dome roof

September 25, 2008

The Indianapolis Department of Parks and Recreation imagines a future where pieces of the RCA Dome roof are sprinkled throughout the city as everything from picnic shelters to shades for pool lifeguards. Director Stuart Lowry said the district hopes to salvage as much of the seven-plus acres of roof as can be taken down safely […]

Lilly anticipates prasugrel decision today

September 26, 2008

Eli Lilly and Co. will learn a lot about its future today. The U.S. Food and Drug Administration is scheduled to rule on Lilly’s new blood-thinner prasugrel today after a nine-month review of clinical trial data. If approved, prasugrel will go on the market immediately under the name Effient. Prasugrel is the first big test […]

Lilly starting next phase of Alzheimer’s trial

October 1, 2008

Eli Lilly and Co. plans to launch a second Phase 3 clinical trial of one of its experimental Alzheimer’s medicines. The Indianapolis-based drugmaker announced today that it hopes to test its gamma secretase inhibitor in 1,100 patients from 22 countries. Doctors will give the drug, known as LY450139, to patients over 21 months, adjusting the […]

Report: Lilly offers $6.1B for ImClone

October 1, 2008

Eli Lilly and Co. is in late talks to acquire ImClone Systems Inc. for $6.1 billion, according to a report on The Wall Street Journal’s Web site. The New York biotech firm develops various medicines for cancer treatments. Lilly would pay $70 per share for ImClone, the Journal said. The deal would be one of […]

ImClone: Suitor due diligence finished

October 2, 2008

ImClone Systems Inc., the New York cancer drug developer said to be in talks to be acquired by Indianapolis-based Eli Lilly and Co., disclosed late yesterday that the suitor had “completed due diligence and made a proposal not subject to financing or further due diligence.” ImClone didn’t identify the suitor, but said it is a […]

Lilly, ImClone shares steady amid merger talk

October 2, 2008

Stock in Indianapolis-based Eli Lilly and Co. and ImClone Systems Inc. fell slightly today – a day after reports surfaced that Lilly has made a $6.1 billion offer for the New York-based cancer drug developer. Lilly shares fell 40 cents to $43.30, and ImClone stock slipped 11 cents to $65.24. The declines came on a […]

Lilly cancer drug deal worth up to $520M

October 3, 2008

Indianapolis-based Eli Lilly and Co. will pay privately held Deciphera Pharmaceuticals LLC of Lawrence, Kan., as much as $520 million to develop and win regulatory approval for four types of cancer drugs, Bloomberg News reported.The companies will collaborate to develop cancer drugs using a Deciphera discovery that seeks to inhibit an enzyme linked to cancer […]

« Previous 1 … 23 24 25 26 27 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

Citizens’ new name is a gas-in a way: Parent company of local utility adds ‘energy’ to its moniker to reflect diversity of operations

Cautious contractors warm to Lilly-Covance deal: Drugmaker works to assuage fears of some local researchers worried they might lose lucrative work

Cymbalta helps lower-back pain, Lilly says

Elanco home base moving to life sciences park

Lilly continues to build case for prasugrel

Zyprexa class action given green light

Commentary: Indiana law chases away talent

ON THE RECORD:

Expectations high as Economic Club opens season: Group sees turnaround in sponsorships, attendance

Lilly Endowment crawls toward diversification goal: Bear market, low Lilly stock price slow selloff

Lilly CEO Lechleiter to become chairman

Orchestrating moves: Firm that specializes in relocating businesses conducting transition of its own

Lilly chief outlines plan to boost stock, image

Parks district to reuse RCA Dome roof

Lilly anticipates prasugrel decision today

Lilly starting next phase of Alzheimer’s trial

Report: Lilly offers $6.1B for ImClone

ImClone: Suitor due diligence finished

Lilly, ImClone shares steady amid merger talk

Lilly cancer drug deal worth up to $520M